Promising
Urolithin A
The prediction game
Call it: rising or fading?
Where does Urolithin A stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: D (early evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 6.5/10
Urolithin A is a 6.5 / 10 fit for people considering mitochondrial, muscle growth, endurance cardio, anti inflammatory, with the strongest case in the populations already represented by the evidence rather than broad wellness use. [Hodzic 2024](https://www.sciencedirect.com/science/article/pii/S1568163724002241) and [Watts 2025](https://www.medrxiv.org/content/10.1101/2025.07.10.25331277v1) give the report its main anchors, while the score stays worth trying because benefits are context-dependent and the evidence still leaves responder, dose, and long-term questions open. Urolithin A makes the most sense when the target is concrete, such as a lab marker, symptom pattern, training limitation, or recovery bottleneck. It makes less sense as a background habit taken on faith. In practice, treat Urolithin A as a tracked experiment: define the outcome first, watch for tradeoffs, and let the response decide whether it earns a place. ✅ Best for: Older adults, sedentary adults, post-illness rebuild phases, and people who suspect poor mitochondrial resilience but want a low-effort intervention. Urolithin A is also more compelling if you are a likely non-producer from ellagitannin foods, because direct supplementation bypasses the gut-bacteria bottleneck described by Selma 2014. Use Mitopure if you want the closest match to the human trial literature. Run it for 12-16 weeks, track something objective, and treat biomarker improvements as more likely than a dramatic felt energy change. ❌ Avoid if: You are price-sensitive, already highly fit, pregnant, nursing, buying unverified generics, or expecting a fast subjective nootropic or energy effect. Avoid using urolithin A as a cancer, cognition, cardiovascular, hormone, or disease-treatment intervention. Francisco 2026 is preclinical colorectal-cancer synthesis, not human treatment evidence. Athletes should also remember that urolithin A was not found as a named WADA-banned substance in the audit, but supplement contamination and label risk still apply.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Promising
- Trend
- Begins with Edition 2
- Momentum
- 11.7%
- BioHarmony Score
- 6.5/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.